LIVE

LocalMost-Viewed Bills - Week of October 25, 2026 MarketsGrab a FREE Sample of Kiehl’s Plumping Serum!BusinessAnthropic begins countdown to IPO with prospectus filing MarketsEQT Stock Slips 4% While Range Resources Shares (RRC) Rally 16% on a $13B Deal TechMatiks raises $10M to expand its math and puzzle gaming platform TechApple Brings TechWoven to iPad With All-New $79 iPad Mini Smart Folio BusinessWhy Some People Are Paying to Make Friends MarketsTD Canadian Aggregate Bond Index ETF declares CAD 0.035 dividend MarketsSoneium Plans $SONEIUM Token for 250+ Apps and a New Entertainment Economy MarketsTD Active Global Enhanced Dividend ETF declares CAD 0.096 dividend MarketsMeta announces $95 billion stock offering to fund AI expansion MarketsInstalled Building Products rated Buy in new coverage at Bank of America WorldIran’s agricultural output rises to 137 million tonnes as yields improve TechMy Co-Worker Hung a Bloody Head Over Our Desks. Is This Normal Office Halloween Decor?MarketsRoss Stores gains after UBS turns bullish TechNew iPad mini shrinks just enough to complicate case compatibility LocalOpen Real Estate: Housing markets must remain open to all MarketsStrategy Skips Bitcoin Buy, Spends $205M Repurchasing STRC Instead MarketsSLB declares $0.295 dividend LocalSign of the times: How does NDOT determine when to replace aging freeway signage?ScienceBarley seed could carry fungicide-resistant disease into next crop, researchers find ScienceAhead of their time: Restricted to pre-2018 research, AI flags hydrogen catalyst reported in later experiments TechKevin Roose is AGI-pilled. Why aren’t you?TechWIRED Ghost Stories MarketsBuy Halloween Candy by the Count – One or Two Pieces per Trick-or-TreaterTRENDING TICKERS: $NTCT $III $DVLT $VG $LSCC $NET $GIL $CALX $QBTS $INV $ASTS $YSS $JKS $FORR $RMNI $PZZA $XTIA $FROG $DOCS $CC $RTX $EQT $XRPN $HIMS $FTK $TZOO $IONQ $GPUS $LDOS $ERICLocalMost-Viewed Bills - Week of October 25, 2026 MarketsGrab a FREE Sample of Kiehl’s Plumping Serum!BusinessAnthropic begins countdown to IPO with prospectus filing MarketsEQT Stock Slips 4% While Range Resources Shares (RRC) Rally 16% on a $13B Deal TechMatiks raises $10M to expand its math and puzzle gaming platform TechApple Brings TechWoven to iPad With All-New $79 iPad Mini Smart Folio BusinessWhy Some People Are Paying to Make Friends MarketsTD Canadian Aggregate Bond Index ETF declares CAD 0.035 dividend MarketsSoneium Plans $SONEIUM Token for 250+ Apps and a New Entertainment Economy MarketsTD Active Global Enhanced Dividend ETF declares CAD 0.096 dividend MarketsMeta announces $95 billion stock offering to fund AI expansion MarketsInstalled Building Products rated Buy in new coverage at Bank of America WorldIran’s agricultural output rises to 137 million tonnes as yields improve TechMy Co-Worker Hung a Bloody Head Over Our Desks. Is This Normal Office Halloween Decor?MarketsRoss Stores gains after UBS turns bullish TechNew iPad mini shrinks just enough to complicate case compatibility LocalOpen Real Estate: Housing markets must remain open to all MarketsStrategy Skips Bitcoin Buy, Spends $205M Repurchasing STRC Instead MarketsSLB declares $0.295 dividend LocalSign of the times: How does NDOT determine when to replace aging freeway signage?ScienceBarley seed could carry fungicide-resistant disease into next crop, researchers find ScienceAhead of their time: Restricted to pre-2018 research, AI flags hydrogen catalyst reported in later experiments TechKevin Roose is AGI-pilled. Why aren’t you?TechWIRED Ghost Stories MarketsBuy Halloween Candy by the Count – One or Two Pieces per Trick-or-TreaterTRENDING TICKERS: $NTCT $III $DVLT $VG $LSCC $NET $GIL $CALX $QBTS $INV $ASTS $YSS $JKS $FORR $RMNI $PZZA $XTIA $FROG $DOCS $CC $RTX $EQT $XRPN $HIMS $FTK $TZOO $IONQ $GPUS $LDOS $ERIC

Skip to content

Monday, October 26, 2026Updated 15:09 UTC

About RSS Submit a release

The excitement around Moderna’s cancer vaccine is cooling. Here’s why.

Source: MarketWatch · Oct 26, 2026 13:50 UTC

Wall Street in New York's Financial District with flags hanging from buildings — File photo Carol M. Highsmith / Library of Congress · Public domain · Source

The Quick Take

Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.

Read the full story at MarketWatch

Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MarketWatch.